BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

231 related articles for article (PubMed ID: 21183791)

  • 1. Spontaneous abrogation of the G₂DNA damage checkpoint has clinical benefits but promotes leukemogenesis in Fanconi anemia patients.
    Ceccaldi R; Briot D; Larghero J; Vasquez N; Dubois d'Enghien C; Chamousset D; Noguera ME; Waisfisz Q; Hermine O; Pondarre C; Leblanc T; Gluckman E; Joenje H; Stoppa-Lyonnet D; Socié G; Soulier J
    J Clin Invest; 2011 Jan; 121(1):184-94. PubMed ID: 21183791
    [TBL] [Abstract][Full Text] [Related]  

  • 2. An ATR- and BRCA1-mediated Fanconi anemia pathway is required for activating the G2/M checkpoint and DNA damage repair upon rereplication.
    Zhu W; Dutta A
    Mol Cell Biol; 2006 Jun; 26(12):4601-11. PubMed ID: 16738325
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Bone marrow failure in Fanconi anemia is triggered by an exacerbated p53/p21 DNA damage response that impairs hematopoietic stem and progenitor cells.
    Ceccaldi R; Parmar K; Mouly E; Delord M; Kim JM; Regairaz M; Pla M; Vasquez N; Zhang QS; Pondarre C; Peffault de Latour R; Gluckman E; Cavazzana-Calvo M; Leblanc T; Larghero J; Grompe M; Socié G; D'Andrea AD; Soulier J
    Cell Stem Cell; 2012 Jul; 11(1):36-49. PubMed ID: 22683204
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Myelodysplasia and leukemia of Fanconi anemia are associated with a specific pattern of genomic abnormalities that includes cryptic RUNX1/AML1 lesions.
    Quentin S; Cuccuini W; Ceccaldi R; Nibourel O; Pondarre C; Pagès MP; Vasquez N; Dubois d'Enghien C; Larghero J; Peffault de Latour R; Rocha V; Dalle JH; Schneider P; Michallet M; Michel G; Baruchel A; Sigaux F; Gluckman E; Leblanc T; Stoppa-Lyonnet D; Preudhomme C; Socié G; Soulier J
    Blood; 2011 Apr; 117(15):e161-70. PubMed ID: 21325596
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Loss of CHK1 function impedes DNA damage-induced FANCD2 monoubiquitination but normalizes the abnormal G2 arrest in Fanconi anemia.
    Guervilly JH; Macé-Aimé G; Rosselli F
    Hum Mol Genet; 2008 Mar; 17(5):679-89. PubMed ID: 18029388
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Knockdown of Chk1 sensitizes human colon carcinoma HCT116 cells in a p53-dependent manner to lidamycin through abrogation of a G2/M checkpoint and induction of apoptosis.
    Pan Y; Ren KH; He HW; Shao RG
    Cancer Biol Ther; 2009 Aug; 8(16):1559-66. PubMed ID: 19502782
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Chk1 is dispensable for G2 arrest in response to sustained DNA damage when the ATM/p53/p21 pathway is functional.
    Lossaint G; Besnard E; Fisher D; Piette J; Dulić V
    Oncogene; 2011 Oct; 30(41):4261-74. PubMed ID: 21532626
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Fanconi anaemia presenting as acute myeloid leukaemia and myelodysplastic syndrome in adulthood: a family report on co-occurring FANCC and CHEK2 mutations.
    Berger G; van den Berg E; Smetsers S; Leegte BK; Sijmons RH; Abbott KM; Mulder AB; Vellenga E
    Br J Haematol; 2019 Mar; 184(6):1071-1073. PubMed ID: 29767408
    [No Abstract]   [Full Text] [Related]  

  • 9. Numerical chromosomal changes and risk of development of myelodysplastic syndrome--acute myeloid leukemia in patients with Fanconi anemia.
    Mehta PA; Harris RE; Davies SM; Kim MO; Mueller R; Lampkin B; Mo J; Myers K; Smolarek TA
    Cancer Genet Cytogenet; 2010 Dec; 203(2):180-6. PubMed ID: 21156231
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Role of ATM and the damage response mediator proteins 53BP1 and MDC1 in the maintenance of G(2)/M checkpoint arrest.
    Shibata A; Barton O; Noon AT; Dahm K; Deckbar D; Goodarzi AA; Löbrich M; Jeggo PA
    Mol Cell Biol; 2010 Jul; 30(13):3371-83. PubMed ID: 20421415
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clonality studies and N-ras and p53 mutation analysis of hematopoietic cells in Fanconi anemia.
    Venkatraj VS; Gaidano G; Auerbach AD
    Leukemia; 1994 Aug; 8(8):1354-8. PubMed ID: 8057673
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Fanconi anemia cells with unrepaired DNA damage activate components of the checkpoint recovery process.
    Rodríguez A; Torres L; Juárez U; Sosa D; Azpeitia E; García-de Teresa B; Cortés E; Ortíz R; Salazar AM; Ostrosky-Wegman P; Mendoza L; Frías S
    Theor Biol Med Model; 2015 Sep; 12():19. PubMed ID: 26385365
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Chromosome abnormalities in bone marrow of Fanconi anemia patients.
    Berger R; Le Coniat M; Schaison G
    Cancer Genet Cytogenet; 1993 Jan; 65(1):47-50. PubMed ID: 8431915
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A role for the Fanconi anemia C protein in maintaining the DNA damage-induced G2 checkpoint.
    Freie BW; Ciccone SL; Li X; Plett PA; Orschell CM; Srour EF; Hanenberg H; Schindler D; Lee SH; Clapp DW
    J Biol Chem; 2004 Dec; 279(49):50986-93. PubMed ID: 15377654
    [TBL] [Abstract][Full Text] [Related]  

  • 15. FANCM and FAAP24 function in ATR-mediated checkpoint signaling independently of the Fanconi anemia core complex.
    Collis SJ; Ciccia A; Deans AJ; Horejsí Z; Martin JS; Maslen SL; Skehel JM; Elledge SJ; West SC; Boulton SJ
    Mol Cell; 2008 Nov; 32(3):313-24. PubMed ID: 18995830
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Upregulated ATM gene expression and activated DNA crosslink-induced damage response checkpoint in Fanconi anemia: implications for carcinogenesis.
    Yamamoto K; Nihrane A; Aglipay J; Sironi J; Arkin S; Lipton JM; Ouchi T; Liu JM
    Mol Med; 2008; 14(3-4):167-74. PubMed ID: 18224251
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Differential roles of checkpoint kinase 1, checkpoint kinase 2, and mitogen-activated protein kinase-activated protein kinase 2 in mediating DNA damage-induced cell cycle arrest: implications for cancer therapy.
    Xiao Z; Xue J; Sowin TJ; Zhang H
    Mol Cancer Ther; 2006 Aug; 5(8):1935-43. PubMed ID: 16928813
    [TBL] [Abstract][Full Text] [Related]  

  • 18. ATR-dependent phosphorylation of FANCM at serine 1045 is essential for FANCM functions.
    Singh TR; Ali AM; Paramasivam M; Pradhan A; Wahengbam K; Seidman MM; Meetei AR
    Cancer Res; 2013 Jul; 73(14):4300-10. PubMed ID: 23698467
    [TBL] [Abstract][Full Text] [Related]  

  • 19. p53-dependent Chk1 phosphorylation is required for maintenance of prolonged G2 Arrest.
    Wang XQ; Stanbridge EJ; Lao X; Cai Q; Fan ST; Redpath JL
    Radiat Res; 2007 Dec; 168(6):706-15. PubMed ID: 18088187
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The effect of the Fanconi anemia polypeptide, FAC, upon p53 induction and G2 checkpoint regulation.
    Kupfer GM; D'Andrea AD
    Blood; 1996 Aug; 88(3):1019-25. PubMed ID: 8704210
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.